Close

Notable Analyst Rating Changes 12/14: (HST) (MRO) (WBMD) Upgraded; (CME) (XOM) (CLWR) Downgraded

December 14, 2012 11:05 AM EST
UPGRADES
Citi raises Host Hotels (NYSE: HST) from Neutral to Buy.

Goldman Sachs boosts Marathon Oil (NYSE: MRO) from Neutral to Buy, moving its price target from $35 up to $39. Click Here for more color.

Raymond James upgrades WebMD Health Corp. (Nasdaq: WBMD) from Underperform to Market Perform.

Pacific Crest lifts Teradyne (NYSE: TER) from Sector Perform to Outperform.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Keefe, Bruyette & Woods trims CME Group (Nasdaq: CME) from Market Perform to Underperform, dropping its price target down $10 to $47.

Goldman Sachs downgrades ExxonMobil (NYSE: XOM) from Buy to Neutral, taking its price target down $3 to $97. Click Here for more color.

Guggenheim cuts Clearwire (Nasdaq: CLWR) from Buy to Neutral. Click Here for more color.

Needham & Company lowers Endo Pharmaceuticals Holdings Inc (Nasdaq: ENDP) from Hold to Underperform. Click Here for more color.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
BofA/Merrill Lynch reinstates PACCAR (Nasdaq: PCAR) with a Buy and $54 target.

Microsoft (Nasdaq: MSFT) started by two today:
  • Janney Montgomery Scott at Neutral and $28 target; and

  • BMO Capital with a Market Perform and $30 price target.

Edward Jones starts Capital One Financial (NYSE: COF) at Buy.

Janney Montgomery Scott commences SAP AG (NYSE: SAP) at Buy and $90 target.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Keefe, Bruyette & Woods, Citi, Raymond James, Needham & Company, BMO Capital, Janney Montgomery Scott, Pacific Crest Securities, Notable Analyst Rating Changes, Edward Jones